Dr. Nathalie Cartier is director of research at Inserm and is running the cell and gene therapy programs in adrenoleukodystrophy, metachromatic leukodystrophy and Alzheimer disease since 1995 at UMR745. Through her achievements in the field and active participation to many international committees in gene therapy, Dr. Nathalie Cartier has gained a worldwilde recognition in the field. Dr. Nathalie Cartier is member of the board of the European Society of Gene Therapy, The French Society of Cellular and Gene Therapy,  COSSEC (Inserm) and DIM-STEM (Stem cells and cellular medecine).